Search results
The life expectancy, survival rate and quality of life after a bone marrow transplant have improved considerably with more accurate genetic matching with donors, following up transplantation with an antibiotic regimen to control infections, and improved post-transplant care, in general.
2 gru 2016 · Data from the Center for International Blood and Marrow Transplant Research (CIBMTR) indicate TRM and relapse rates of 30% and 30%, respectively, after allogeneic HCT from human leukocyte antigen (HLA)-matched related donors; the 3-year probability of survival is 40%. 4 Survival rates improved over the past decade, and recent studies indicate ...
7 gru 2022 · Myelodysplastic syndrome (MDS) is a type of cancer in which the bone marrow does not produce healthy cells. Find out here about the outlook and life expectancy for a person with MDS.
Median survival is one way to look at outcomes. It is the time after diagnosis at which half the patients in a certain group are still alive, and half have died. This is a middle value – half the patients live longer than this, and half do not live this long. Survival statistics don't tell the whole story.
9 mar 2022 · We determined trends in life expectancy and cause-specific late mortality after autologous blood or marrow transplantation (BMT) performed over a 30-year period, using the BMT Survivor Study. Methods.
17 mar 2011 · It can lead to joint pain, bone destruction, and loss of function with significant impairment in quality of life. 8,9,79-81 The mean time from transplantation to avascular necrosis is 1 to 2 years after HCT, and pain and limited activity are usually the first sign. The hip is the most affected site in a majority of cases, but multiple-site ...
4 kwi 2011 · The prospect for long-term survival is excellent for 2-year survivors of allogeneic HCT. However, life expectancy remains lower than expected. Performance of HCT earlier in the course of disease, control of GVHD, enhancement of immune reconstitution, less toxic regimens, and prevention and early treatment of late complications are needed.
